Effect of thalidomide, octreotide, and prednisolone on the migration and proliferation of RPE cells in vitro

Current Eye Research

Volumn 19, Issue 6, 1999, Pages 483-490

  Spraul, Christoph W ^a,b   Kaven, Corinna ^a   Kampmeier, Jürgen ^a   Lang, Gerhard K ^a   Lang, Gabriele E ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Age related macular degeneration, choroidal neovascularization, prednisolone; Cell migration; Cell proliferation; Octreotide, retinal pigment epithelium, thalidomide

Indexed keywords

ANGIOGENESIS INHIBITOR; OCTREOTIDE; PREDNISOLONE; THALIDOMIDE; THYMIDINE; TRITIUM;

ANIMAL CELL; ARTICLE; BIOASSAY; CATTLE; CELL COUNT; CELL CULTURE; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; STAINING; STATISTICAL ANALYSIS; SUBRETINAL NEOVASCULARIZATION;

EID: 0033374052     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.19.6.483.5281     Document Type: Article

References (44)

1. Young RW. Pathophsiology of age-related macular degeneration. Surv Ophthalmol. 1987;31:291-306.
2. Miller H, Miller B, Ishibashi T, Ryan SJ. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci. 1990;31:899-908.
3. Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci. 1986;27:1644-1652.
4. Spraul CW, Lang GE, Yoon HS, Grossniklaus HE, Lang GK. Characteristics and classification of sugically-excised choroidal neovascular membranes. Klin Monatsbl Augenheilkd. 1997;211:324-334.
5. Glaser BM, Campochiaro PA, Davis JL, Jerdan LA. Retinal pigment epithelial cells release inhibitors of neovascularization. Ophthalmology 1987;94:780-784.
6. Glaser BM, Campochiaro PA, Davis JL, Sato M. Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol. 1985;103:1870-1875.
7. Kuijpers RWAM, Vmgerling JR, Mooij CM, Van Hagen PM. Treatment of exsudative neovascular macular degeneration with octreotide. Ophthalmic Surg. 1998;30 (Suppl 1):S73.
8. Snyder RK, Runge PE. Thalidomide and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 1998;39 (Suppl):S385.
9. He S, Wang HM, Ye J, Ogden TE, Ryan SJ, Hinton DR. Dexamethasone induced proliferation of cultured retinal pigment epithelial cells. Curr Eye Res. 1994;13:257-261.
10. Ip M, Gorin MB. Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide. Am J Ophthalmol. 1996;122:594-595.
11. Ishibashi T, Miki K, Sorgente N. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 1985;103:708-711.
12. Joussen M, Kruse FE, Becker M, Rohrschneider K, Völcker HE. Thalidomide inhibits angiogenesis induced by vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1998;38 (Suppl):S359.
13. Kishimoto N, Uyama M, Fukushima I, Yamada K, Nishikawa M, Ohkuma H. The effect of corticoid on th repair of the retinal pigment epithelium. Nippon Ganka Gakkai Zasshi. 1993;97:360-369.
14. Koutsandrea CN, Miceli MV, Peyman GA, Farahat HG, Niesman MR. Ciprofloxacin and dexamethasone inhibit the proliferation of human retinal pigment epithelial cells in culture. Curr Eye Res. 1991;10:249-258.
15. Luo Q, Peyman GA, Conway MD, Woltering EA. Effect of a somatostatin analog (octreotide acetate) on the growth of retinal pigment epithelial cells in culture. Curr Eye Res. 1996;15:909-913.
16. Penfold P, Gyory J, Hunyor A, Billson F. Exsudative macular degeneration and intravitreal triamcinolone. Aust N Z J Ophthalmol. 1995;23:293-298.
17. Campochiaro PA, Jerdan JA, Glaser BM. Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol. 1984;102:1830-1833.
18. Murphy TL, Sakamoto T, Hinton DR, Spec C, Gundimda UG, Soriano D, Gopalakrishna R, Ryan SJ. Migration of retinal pigment epithelium cells in vitro is regulated by protein kinase C. Exp Eye Res 1995;60:683-695.
19. Sakamoto T, Hinten DR, Kimura H, Spec C, Gopalakrishna R, Ryan SJ. Vitamin E succinate inhibits proliferation and migration of retinal pigment epithelial cells in vitro: therapeutic implication for proliferative retinopathy. Graefe's Arch Clin Exp Ophthalmol. 1996;234:186-192.
20. D'Amato R, Loughnan M, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA. 1994;91:4082-4085.
21. Smith JP, Solomon TE. Effect of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology. 1988;95:1541-1548.
22. Taylor JE, Moreau JP, Baptiste L, Moody TW. Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells. Peptides. 1991;12:839-843.
23. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells;a potential treatment for restenosis ? Circulation. 1994;89:1511-1517.
24. Grant MB, Caballero S, Millard WJ. Inhibition of IGF-I and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neovascularization. Regul Pept. 1993;20:267-278.
25. Folkman J, Ingber D. Angiostatic steroids. Ann Surg. 1987;206:374-382.
26. Bauer KS, Dixon SC, Figg WD. Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent. Biochem Pharmacol. 1998;55:1827-1834.
27. Parmar H, Bogden A, Mollard M, de Rougé B, Phillips RH, Lightman SL. Somatostatin and somatostatin analogues in oncology. Cancer Treat Rev. 1989;16:95-115.
28. Kothary PC, Varde N, Del Monte MA. Somatostatin inhibits human retinal pigment epithelial cell proliferation (Abstract). Second International Symposium on Experimental and Clinical Pharmacology and Pharmaceutics in Munich from 11. - 14. 09. 1997, 1997;:S39.
29. Prévost G, Foehrlé E, Thomas F, Pihan I, Veber N, Starzec A, Israël L. Growth of human breast cancer cell lines is inhibited by somatostatin analog BIM23014. Endocrinology. 1991;129:323-329.
30. Setyono-Han B, Henkelman MS, Foekens JA, Klijn JGM. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 1987;47:1566-1570.
31. Danesi R, Agen C, Benelli U, Paola AD, Nardini D, Bocci G, Basolo F, Campagni A, Tacca MD. Inhibition of experimental angiogenesis by the somatostatin analgoue. Clin Can Res. 1997;3:265-272.
32. Fiscella R, Peyman GA, Elvart J, Yue B. In vitro evaluation of cellular inhibitory potential of various antineoplastic drugs and dexamethasone. Ophthalmic Surg. 1985;16:247-249.
33. Tano Y, Sugita G, Abrams G, Machemer R. Inhibition of intraocular proliferations with intravitreal corticosteroids. Am J Ophthalmol. 1980;89:131-136.
34. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980;90:810-816.
35. Blumenkranz MS, Claffin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease: cell culture evaluation. Arch Ophthalmol. 1984;102:598-604.
36. Bourcier T, Borderie V, Forgez P, Lombet A, Rosène W, Laroche L. In vitro effect of dexamethasone on human corneal keratocytes. Invest Ophthalmol Vis Sci. 1999;40:1061-1070.
37. Fyfe AI, Rosenthal A, Gotlieb AI. Immunosuppresive agents and endothelial repair. Prednisolone delays migration and cytoskeletal rearrangement in wounded porcine aortic monolayers. Arterioscler Thrombo. 1995;15:1166-1171.
38. Iio H, Ake Y, Saegusa Y, Mizuno K. The effect of lipid peroxide on osteoblasts and vascular enoothelial cells - the possible role of ischemia-reperfusion in the progression of avascular necrosis of the femoral head. Kobe J Med Sci. 1996;42:361-373.
39. Järveläinen H, Pelliniemi TT, Ronnemaa T. The stabilizing effect of glucocorticoids on human endothelial cells in culture. Scand J Clin Lab Invest. 1985;45:223-228.
40. Schönfeld C-L. Expression of the nuclear glucocorticoid receptor in the human retinal pigment epithelium. Ophthalmologe. 1998;95:400-403.
41. O'Malley BW, Means AR. Female steroid hormones and target cell nuclei. The effect of steroid hormones on target cell nuclei are of major importance in the induction of new cell function. Science. 1974;183:610-620.
42. Frisch SM, Ruley HE. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem. 1987;262:16300-16304.
43. Schönfeld CL. Expression of the metalloproteinase stromelysin in the human retinalen pigment epithelium. Ophthalmologe. 1997;94:629-633.
44. Wang E, Warner RH (1989) Growth Control During Cell Aging. Boca Raton, F1: CRC Press,